Checchi Capital Advisers’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.07M | Buy |
9,863
+221
| +2% | +$224K | 0.46% | 52 |
|
|
2025
Q4 | $10.4M | Sell |
9,642
-209
| -2% | -$200K | 0.53% | 44 |
|
|
2025
Q3 | $7.52M | Sell |
9,851
-805
| -8% | -$599K | 0.39% | 56 |
|
|
2025
Q2 | $8.31M | Sell |
10,656
-403
| -4% | -$313K | 0.46% | 51 |
|
|
2025
Q1 | $9.13M | Buy |
11,059
+315
| +3% | +$262K | 0.48% | 46 |
|
|
2024
Q4 | $8.29M | Buy |
10,744
+1
| +0% | +$828 | 0.48% | 50 |
|
|
2024
Q3 | $9.52M | Sell |
10,743
-234
| -2% | -$210K | 0.53% | 40 |
|
|
2024
Q2 | $9.94M | Buy |
10,977
+111
| +1% | +$88.8K | 0.5% | 36 |
|
|
2024
Q1 | $8.45M | Buy |
10,866
+46
| +0.4% | +$32.7K | 0.66% | 43 |
|
|
2023
Q4 | $6.31M | Sell |
10,820
-347
| -3% | -$203K | 0.51% | 56 |
|
|
2023
Q3 | $6M | Sell |
11,167
-100
| -0.9% | -$51.5K | 0.56% | 46 |
|
|
2023
Q2 | $5.28M | Buy |
11,267
+71
| +0.6% | +$29.8K | 0.47% | 57 |
|
|
2023
Q1 | $3.84M | Buy |
11,196
+169
| +2% | +$57K | 0.37% | 62 |
|
|
2022
Q4 | $4.03M | Sell |
11,027
-52
| -0.5% | -$18.4K | 0.42% | 61 |
|
|
2022
Q3 | $3.58M | Buy |
11,079
+33
| +0.3% | +$10.5K | 0.33% | 69 |
|
|
2022
Q2 | $3.64M | Sell |
11,046
-412
| -4% | -$124K | 0.32% | 66 |
|
|
2022
Q1 | $3.28M | Buy |
11,458
+1,672
| +17% | +$430K | 0.28% | 68 |
|
|
2021
Q4 | $2.7M | Buy |
9,786
+122
| +1% | +$30.9K | 0.24% | 73 |
|
|
2021
Q3 | $2.23M | Buy |
9,664
+167
| +2% | +$41.2K | 0.22% | 79 |
|
|
2021
Q2 | $2.18M | Sell |
9,497
-414
| -4% | -$83.2K | 0.21% | 86 |
|
|
2021
Q1 | $1.85M | Sell |
9,911
-195
| -2% | -$38.1K | 0.18% | 95 |
|
|
2020
Q4 | $1.71M | Buy |
10,106
+156
| +2% | +$23.3K | 0.18% | 97 |
|
|
2020
Q3 | $1.47M | Sell |
9,950
-294
| -3% | -$45.5K | 0.16% | 92 |
|
|
2020
Q2 | $1.68M | Sell |
10,244
-439
| -4% | -$67.4K | 0.2% | 80 |
|
|
2020
Q1 | $1.48M | Buy |
10,683
+233
| +2% | +$32K | 0.14% | 77 |
|
|
2019
Q4 | $1.37M | Sell |
10,450
-108
| -1% | -$12.5K | 0.18% | 90 |
|
|
2019
Q3 | $1.18M | Sell |
10,558
-112
| -1% | -$12.5K | 0.15% | 94 |
|
|
2019
Q2 | $1.18M | Sell |
10,670
-680
| -6% | -$80.1K | 0.15% | 92 |
|
|
2019
Q1 | $1.47M | Sell |
11,350
-185
| -2% | -$22.5K | 0.17% | 79 |
|
|
2018
Q4 | $1.33M | Sell |
11,535
-745
| -6% | -$83.2K | 0.17% | 78 |
|
|
2018
Q3 | $1.32M | Buy |
12,280
+1,287
| +12% | +$129K | 0.15% | 92 |
|
|
2018
Q2 | $938K | Buy |
10,993
+282
| +3% | +$23.2K | 0.12% | 111 |
|
|
2018
Q1 | $829K | Buy |
10,711
+196
| +2% | +$15.8K | 0.11% | 123 |
|
|
2017
Q4 | $888K | Buy |
10,515
+186
| +2% | +$15.8K | 0.12% | 107 |
|
|
2017
Q3 | $884K | Sell |
10,329
-110
| -1% | -$9.02K | 0.09% | 101 |
|
|
2017
Q2 | $859K | Sell |
10,439
-864
| -8% | -$70.5K | 0.09% | 103 |
|
|
2017
Q1 | $951K | Sell |
11,303
-818
| -7% | -$65.5K | 0.11% | 94 |
|
|
2016
Q4 | $891K | Sell |
12,121
-43
| -0.4% | -$3.2K | 0.12% | 99 |
|
|
2016
Q3 | $976K | Buy |
12,164
+294
| +2% | +$23.5K | 0.11% | 86 |
|
|
2016
Q2 | $935K | Sell |
11,870
-703
| -6% | -$52.9K | 0.11% | 85 |
|
|
2016
Q1 | $905K | Buy |
12,573
+604
| +5% | +$45.7K | 0.2% | 85 |
|
|
2015
Q4 | $1.01M | Buy |
11,969
+794
| +7% | +$65.9K | 0.25% | 84 |
|
|
2015
Q3 | $935K | Buy |
11,175
+392
| +4% | +$33.1K | 0.25% | 76 |
|
|
2015
Q2 | $900K | Buy |
10,783
+787
| +8% | +$60K | 0.24% | 81 |
|
|
2015
Q1 | $726K | Buy |
9,996
+881
| +10% | +$62.7K | 0.21% | 92 |
|
|
2014
Q4 | $629K | Buy |
9,115
+1,014
| +13% | +$68.4K | 0.24% | 90 |
|
|
2014
Q3 | $525K | Buy |
8,101
+1,601
| +25% | +$101K | 0.22% | 98 |
|
|
2014
Q2 | $404K | Buy |
6,500
+408
| +7% | +$24.3K | 0.18% | 102 |
|
|
2014
Q1 | $359K | Buy |
6,092
+902
| +17% | +$50.3K | 0.22% | 89 |
|
|
2013
Q4 | $265K | Buy |
+5,190
| New | +$260K | 0.21% | 104 |
|
Other funds holding LLY
VCM
VPM
Checchi Capital Advisers's LLY Position: Q1 2026 in Review
Checchi Capital Advisers increased its Eli Lilly (LLY) stake by 2.3% in Q1 2026, buying an estimated $224K and bringing the position to 9,863 shares worth $9.07M. The position accounts for 0.46% of the portfolio, ranked #52.
Checchi Capital Advisers first reported a position in LLY in Q4 2013 and has held it in 50 quarters since. The position peaked at $10.4M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Checchi Capital Advisers held 9,863 shares of Eli Lilly worth $9.07M as of Q1 2026.
- Checchi Capital Advisers bought 221 Eli Lilly shares in Q1 2026, an estimated $224K.
- Eli Lilly made up 0.46% of Checchi Capital Advisers's portfolio in Q1 2026, its #52 holding.
- Checchi Capital Advisers first reported a position in Eli Lilly in Q4 2013 and has held it in 50 quarters since.
- Checchi Capital Advisers's Eli Lilly position peaked at $10.4M in Q4 2025.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Checchi Capital Advisers's 13F filing for Q1 2026, filed 4 May 2026.